Panel includes:
	Amikacin, Cefoxitin, Ciprofloxacin, Clarithromycin, Doxycycline, Imipenem, Linezolid, Moxifloxacin, Tigecycline, Tobramycin, Trimethoprim/Sulfamethoxazole In order to perform susceptibility testing and to interpret test results, the identification of the isolate is required.

*This test was performed using a kit that has not been cleared or approved by the FDA. The analytical performance characteristics of this test have been determined by Focus Diagnostics. This test should not be used for diagnosis without confirmation by other medically established means.

This test is approved for New York patient testing.

 Antimicrobial Testing